Doran, R. C., Tatsuno, G. P., O’Rourke, S. M., Yu, B., Alexander, D. L., Mesa, K. A., & Berman, P. W. (2018). Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies. PLoS One.

Doran, Rachel C., Gwen P. Tatsuno, Sara M. O’Rourke, Bin Yu, David L. Alexander, Kathryn A. Mesa, και Phillip W. Berman. "Glycan Modifications to the Gp120 Immunogens Used in the RV144 Vaccine Trial Improve Binding to Broadly Neutralizing Antibodies." PLoS One 2018.

Doran, Rachel C., et al. "Glycan Modifications to the Gp120 Immunogens Used in the RV144 Vaccine Trial Improve Binding to Broadly Neutralizing Antibodies." PLoS One 2018.